Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin, Rifabutin, and Fluconazole for MAC and Fungal Prophylaxis in HIV
NCT00002122Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azithromycin, rifabutin and fluconazole in Mycobacterium avium complex infection (MAC) and mycosis, sponsored by Pfizer. Status: completed.
02
Drugs
azithromycinrifabutinfluconazole
03
Conditions
Mycobacterium avium complex infection (MAC)mycosis
Beyond the preview
Go deeper on NCT00002122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002122.